Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

Background: Immune checkpoint inhibitors (ICIs) have significantly changed the current approach to cancer treatment. Although the use of ICIs has become the standard of care for advanced melanoma, reports of ICI use among Asian populations with melanoma are limited. Therefore, we conducted this retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chiao-En, Yang, Chan-Keng, Peng, Meng-Ting, Huang, Pei-Wei, Lin, Yu-Fen, Cheng, Chi-Yuan, Chang, Yao-Yu, Chen, Huan-Wu, Hsieh, Jia-Juan, Chang, John Wen-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287159/
https://www.ncbi.nlm.nih.gov/pubmed/32582554
http://dx.doi.org/10.3389/fonc.2020.00905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287159/
https://www.ncbi.nlm.nih.gov/pubmed/32582554
http://dx.doi.org/10.3389/fonc.2020.00905

Ejemplares similares